[Federal Register Volume 79, Number 215 (Thursday, November 6, 2014)]
[Notices]
[Page 65979]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-26422]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, Program on Biosecurity and Biosafety 
Policy; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the meeting of the 
National Science Advisory Board for Biosecurity (NSABB).
    Name of Committee: National Science Advisory Board for Biosecurity.
    Date: November 25, 2014.
    Time: 11:00 a.m.-1:00 p.m. Eastern. The teleconference line will be 
open at 10:30 a.m. to allow for check-in with the operator. (Times are 
approximate and subject to change.)
    Agenda: Discussion regarding: (1) Finalization of draft NSABB 
statement regarding gain-of-function research; and (2) other business 
of the Board. Time will be allotted on the agenda for oral public 
comment, with presentations limited to three minutes per speaker.
    Place: National Institutes of Health, 6705 Rockledge Drive, Suite 
750, Bethesda, Maryland. (Telephone Conference call only; No in-person 
meeting.)
    Call-in Information: Toll-Free Number: 1-888-469-1981. Participant 
Passcode: NSABB. The line will be open 30 minutes in advance of the 
meeting to allow time for operator-assisted check-in.
    Contact Person: Carolyn Mosby, NSABB Program Assistant, NIH Program 
on Biosecurity and Biosafety Policy, 6705 Rockledge Drive, Suite 750, 
Bethesda, Maryland 20892, (301) 435-5504, [email protected].
    Under authority 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established the NSABB to provide advice regarding federal oversight of 
dual use research, defined as biological research that generates 
information and technologies that could be misused to pose a biological 
threat to public health and/or national security.
    Please Note: The teleconference meeting agenda, draft statement, 
and other information about the NSABB will be available at http://osp.od.nih.gov/office-biotechnology-activities/biosecurity/nsabb. 
Please check this Web site for updates.
    The meeting will be open to the public through a teleconference 
call phone number. Members of the public who participate in the 
teleconference will be able to listen to the meeting but will not be 
heard apart from during the public comment session. If you experience 
any technical problems with the conference call, please send an email 
to [email protected].
    Public Comments: The teleconference will include opportunity for 
public comment. In addition, any interested person may file written 
comments with the committee via email to [email protected] with ``NSABB 
Public Comment'' as the subject line or by regular mail to 6705 
Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention: Carolyn 
Mosby. Comments should include the name, address, telephone number and, 
when applicable, the business or professional affiliation of the 
commenter. Written comments received by 5:00 p.m. (Eastern) on Sunday 
November 23, 2014, will be provided to NSABB members prior to the 
teleconference.
    Accommodations Statement: Individuals who participate by using this 
teleconference call service and who need special assistance such as 
captioning or other reasonable accommodations should submit a request 
to the Contact Person listed on this notice as soon as possible.

    Dated: November 3, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-26422 Filed 11-5-14; 8:45 am]
BILLING CODE 4140-01-P